-
Mugglehead
Jul 31, 2020, 7:46 pm259 ptsNovel drug developer Revive Therapeutics Ltd. (CSE: RVV) hit a major milestone this week receiving U.S. Food and Drug Administration approval to begin a Phase 3 trial of its lead drug Bucillamine to treat patients with Covid-19. On Friday, the Toronto-based company said the confirmatory Phase 3 clinical will be…
Trending Today on NewsBudz
NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.
Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.